Skip to main content

MoneyWorks4Me

Zydus Lifesciences informs about press release

18 Jul 2022 Evaluate

Zydus Lifesciences has informed that it enclosed a copy of press release dated July 18, 2022 titled ‘Zydus receives final approval from the USFDA for Efinaconazole Topical Solution’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1919.45
Dr. Reddys Labs. 1379.00
Cipla 1410.55
Lupin 1997.95
Zydus Lifesciences 1204.20
View more..